Pulmonary Fibrosis News Columnist and Forum Moderator Charlene Marshall reads an article summarizing a poster presented at the virtual American Thoracic Society (ATS) conference earlier this month. The poster captures data from a recent trial showing the effectiveness and benefit(s) of using Ofev to preserve lung function and help manage various forms of progressive interstitial lung diseases (ILDs).
Are you interested in learning more about Pulmonary Fibrosis? If so, please visit: https://pulmonaryfibrosisnews.com